GlassScriptPhysician profile
Robert L Hall
NPI 1184484834
$2,389.86
in general payments reported to CMS, 2019-2025
16 companies · $2,056 in 2025
The $2,056 reported for 2025 was more than what 96% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $334 · 2025: $2,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,389.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $912.87 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $427.86 | 2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $206.69 | 2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Phathom Pharmaceuticals, INC. | $181.88 | 2025 | Voquezna |
| Boston Scientific Corporation | $149.45 | 2025 | Intracept |
| Eisai INC. | $114.13 | 2024 | |
| Esperion Therapeutics, INC. | $97.98 | 2024-2025 | Nexletol |
| Novo Nordisk INC | $71.18 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $52.21 | 2025 | Repatha, Otezla |
| Pfizer INC. | $50.97 | 2025 | |
| Lilly USA, LLC | $27.71 | 2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $23.19 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $21.40 | 2025 | Vyepti |
| Orthofix Medical, INC. | $21.28 | 2024 | Physio-Stim, Accelstim |
| Merck Sharp & Dohme LLC | $17.02 | 2025 | Gardasil 9, Capvaxive |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $14.04 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.